For the year ending 2025-12-31, NYT had $57,034K increase in cash & cash equivalents over the period. $550,505K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Impairment on indefinite-lived asset | - | - | - | 4,069 |
| Gain on the sale of land | - | 0 | 0 | 34,227 |
| Lease termination charge | - | - | 0 | 0 |
| Net income | 343,981 | 293,825 | 232,752 | 173,905 |
| Depreciation and amortization | 85,007 | 82,936 | 86,115 | 82,654 |
| Amortization of right of use asset | 10,142 | 9,088 | 9,232 | 9,923 |
| Stock-based compensation expense | 74,183 | 67,499 | 54,776 | 35,306 |
| Gain on non-marketable equity investment | - | - | 0 | 0 |
| Multiemployer pension plan liability adjustments | -2,967 | 2,980 | - | - |
| Impairment charges | 2,858 | 0 | 15,239 | - |
| Gain from joint ventures | 0 | 0 | 2,477 | 0 |
| Change in long-term retirement benefit obligations | -10,633 | -25,051 | -29,528 | -29,049 |
| Pension settlement expense | - | - | - | 0 |
| Fair market value adjustment on life insurance products | 400 | 1,923 | 1,648 | -1,081 |
| Other net | 1,422 | -7,446 | 3,932 | -3,005 |
| Accounts receivable net | 41,293 | 7,042 | 24,955 | -20,889 |
| Other current assets | -36,341 | -2,403 | 2,154 | 23,220 |
| Accounts payable, accrued payroll and other liabilities | 55,650 | -21,031 | -7,321 | -111,216 |
| Unexpired subscriptions | 20,541 | 14,310 | 16,827 | 8,588 |
| Multiemployer pension plan liability adjustment | - | - | 605 | -14,989 |
| Other noncurrent assets and liabilities | -3,723 | -5,924 | -10,433 | - |
| Net cash provided by operating activities | 584,489 | 410,512 | 360,618 | 150,687 |
| Purchases of marketable securities | 652,705 | 479,975 | 286,448 | 6,648 |
| Maturities/disposals of marketable securities | 452,309 | 190,592 | 142,161 | 484,984 |
| Proceeds from/(purchases of) investments | -246 | 42 | -2,512 | 1,832 |
| Capital expenditures | 33,984 | 29,173 | 22,669 | 36,961 |
| Business acquisitions | - | 0 | 0 | 515,586 |
| Other net | -12,818 | -12,512 | -4,754 | -2,482 |
| Net cash used in investing activities | -221,316 | -306,086 | -159,690 | -73,561 |
| Dividends paid | 110,363 | 82,855 | 69,464 | 56,790 |
| Stock issuances | - | 0 | 0 | 3 |
| Payment of contingent consideration | 431 | 3,017 | 3,448 | 2,586 |
| Purchase of noncontrolling interest | 0 | 0 | 356 | - |
| Repurchases | 165,341 | 85,043 | 44,553 | 105,056 |
| Share-based compensation tax withholding | 30,004 | 21,800 | 14,889 | 9,877 |
| Net cash used in financing activities | -306,139 | -192,715 | -132,710 | -174,306 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | 57,034 | -88,289 | 68,218 | -97,180 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -430 | - | - | - |
| Cash, cash equivalents and restricted cash at the beginning of the year | 213,857 | - | - | - |
| Cash, cash equivalents and restricted cash at the end of the year | 270,461 | - | - | - |
NEW YORK TIMES CO (NYT)
NEW YORK TIMES CO (NYT)